Preparation and biodistribution in mice of [11C]carfentanil: A radiopharmaceutical for studying brain μ-opioid receptors by positron emission tomography
- 47 Downloads
A potent μ-opioid agonist, [11C]carfentanil, was prepared by the methylation of carfentanil carboxylic acid with [11C]methyl iodide in order to study brain μ-opioid receptors by positron emission tomography. Synthesis (including purification) was completed within 25 min and the radiochemical yield was approximately 40%. The radiochemical purity of the product was more than 99% and its specific activity was 3.7–7.4 GBq/μmol. Biodistribution studies performed in mice after intravenous injection showed a high brain uptake and rapid blood clearance, so a high brain/blood ratio of 1.5–1.8 was found from 5 to 30 min. Regional cerebral distribution studies in the mouse showed a significantly higher uptake of [11C]carfentanil by the thalamus and striatum than by the cerebellum, with the radioactivity in the striatum disappearing more rapidly than that in the thalamus. Treatment with naloxone significantly reduced the uptake of [11C]carfentanil by the thalamus and striatum. These results indicate that [11C]carfentanil binds specifically to brain μ-opioid receptors.
Key words[11C]carfentanil synthesis biodistribution opioid receptor positron emission tomography
Unable to display preview. Download preview PDF.
- 5.Mayberg HS, Frost JJ: Opiate receptors. In Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes, Frost JJ, Wagner HN, (eds.), New York, Raven Press, pp 81–95, 1990Google Scholar
- 6.Sedvall G, Farde L, Kopp J, et al: Visualization of neuroreceptor functions in the living human brain. In Visualization of Brain Functions, Ottoson D, Rostene W, (eds.), New York, Stockton Press, pp 159–165, 1989Google Scholar
- 7.Kung HF: Radiopharmaceuticals for CNS receptor imaging with SPECT.Nucl Med Biol 17: 85–92, 1990Google Scholar
- 8.Van Daele PGH, De Bruyn MFL, Boey JM, et al: Synthetic analgesics: N(1-[2-aryl ethyl]-4-substituted 4-piperidinyl)N-arylalkanamides.Arzneim Forsch (Drug Res) 26: 1521–1531, 1976Google Scholar
- 18.Fowler JS, Wolf AP: Positron emitter labeled compounds: priorities and problems. In Positron Emission Tomography and Autoradiography: Principles and Applications for The Brain and Heart, Phelps M, Mazziotta J, Schelbert H, (eds.), New York, Raven Press, pp 391–450, 1986Google Scholar
- 20.Dannals RF, Ravert HT, Wilson AA: Radiochemistry of tracers for neurotransmitter receptor studies. In Quantitative Imaging: Neuroreceptors, Neurotransmitters, and Enzymes, Frost JJ, Wagner HN, (eds.), New York, Raven Press, pp 19–35, 1990Google Scholar
- 21.Parterson SJ, Robson LE, Kosterlitz HW: Opioid receptors. In The Peptides: Analysis, Synthesis, Biology, Vol 6, Vdenfriend S, Meienhofer J, (eds.), London, Academic Press, pp 147–189, 1984Google Scholar